OOIR: Observatory of International Research

Papers

(The median citation count of Best Practice & Research in Clinical Rheumatology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
The importance of functional genomics studies in precision rheumatology	88
A review of the advances in understanding the genetic basis of spondylarthritis and emerging clinical benefit	78
Editorial Board	71
Novel therapies – IMID Co-morbidities	60
Update of imaging in the assessment of axial spondyloarthritis	54
Rehabilitation interventions in osteoarthritis	42
Possible future avenues for myositis therapeutics: DM, IMNM and IBM	40
Pathophysiology and immunolgical basis of axial spondyloarthritis	39
Novel therapies in Sjögren’s disease: A systematic review of the literature	37
Rheumatic manifestations of HIV/AIDS	37
Epidemiology of rheumatic diseases in tropical populations	33
The inequity of global healthcare in pediatric rheumatology	29
Novel therapies for axial spondyloarthritis and future directions	27
Environmental factors and rheumatic diseases	27
The communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus	26
Index for PART A	25
Potential therapeutic targets of fibrosis in inflammatory rheumatic diseases	25
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis	24
Genetics of rheumatoid arthritis	23
Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus	23
Editorial Board	22
Genetics of osteoarthritis	22
The role of ultrasound and magnetic resonance imaging in the assessment of musculoskeletal involvement in systemic lupus erythematosus: A review of recent advances and insights	22
Osteoporosis in 2022: Care gaps to screening and personalised medicine	22
Diagnostic delay in axial spondylarthritis: A lost battle?	21

Classification of systemic lupus erythematosus: From the development of classification criteria to a new taxonomy?	21
Novel therapies and innovation for systemic sclerosis skin ulceration	20
Where is bone science taking us?	20
Index	19
Editorial Board	19
Systemic lupus erythematosus	19
Patient-reported outcomes in vasculitis	19
Imaging of crystal-induced arthropathies in 2025	19
Physiotherapy and occupational therapy in rheumatoid arthritis: Bridging functional and comorbidity gaps	19
Preclinical RA: How to halt its progression	19
Lacrimal and salivary gland ultrasound - how and when to use in patients with primary Sjögren's syndrome	18
Pregnancy & neonatal outcomes in spondyloarthritis	18
Calcinosis in dermatomyositis: Origins and possible therapeutic avenues	18
Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment	18
Editorial Board	18
The burden of osteoarthritis: Is it a rising problem?	18
New and future therapies: Changes in the therapeutic armamentarium for SLE	17
Imaging rheumatology: Emerging tools and expanding applications	17
Bedside labial salivary gland biopsy (LSGBx: Lip biopsy): An update for rheumatologists	17
Problems with “Problems with opioids beyond misuse”	17
Editorial Board	16
Exercise in myositis: What is important, the prescription or the person?	16
Novel therapies in treatments of SLE	16
Infection associated Vasculitides	16
Risk for osteoporosis and fracture with glucocorticoids	16
Granzyme K+ CD8 T cells in autoimmunity	15
Pregnancy in systemic lupus erythematosus	15
Index	14
Personalized medicine in rheumatoid arthritis: Combining biomarkers and patient preferences to guide therapeutic decisions	14
Best practice and research advances in many aspects of rheumatology	14
Pharmacogenetics of therapies in rheumatoid arthritis: An update	14
Emerging insights in tropical rheumatology: Challenges, clinical manifestations, and recent advances	14
Editorial Board	14
What the rheumatologist needs to know about skin biopsy	13
Regenerative methods in osteoarthritis	13
Kidney involvement in systemic lupus erythematosus: From the patient assessment to a tailored treatment	13
Treatment of rheumatic adverse events of cancer immunotherapy	12
Translational implications of newly characterized pathogenic pathways in systemic lupus erythematosus	12
Exploring osteoarthritis: Unraveling challenges, innovations, and hope for a better future	12
Idiopathic inflammatory myopathies: Progress, challenges, and future perspectives	12
Prediction of treatment response: Personalized medicine in the management of rheumatoid arthritis	12
Pain in osteoarthritis from a symptom to a disease	11
Musculoskeletal complications in sickle cell disease: Pathophysiology, diagnosis and management	11
Recent targets of osteoarthritis research	11
Synovial fluid analysis: Relevance for daily clinical practice	11
When are patients with osteoarthritis referred for surgery?	11
Impact of sex and gender on axSpA diagnosis and outcomes	11
IgG4-Related disease: From diagnosis to remission	10
Editorial Board	10
Index	10

Practical utilization of sonography for the assessment of muscle diseases in rheumatology	10
Muscle imaging in myositis: MRI, US, and PET	10
Osteoporosis evaluation and treatment recommendations in rheumatoid arthritis	10
CARD9 in the pathogenesis of axial spondyloarthritis	9
Femoroacetabular impingement – What the rheumatologist needs to know	9
TNFR2 signalling in inflammatory diseases	9
Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?	9
Interferonopathies: From concept to clinical practice	9
Novel Therapy	8
Pain syndromes	8
Preface: Pediatric rheumatology	8
Exploring the role of gut microbes in spondyloarthritis: Implications for pathogenesis and therapeutic strategies	7
Imaging in sarcoid disease	7
The global burden of fragility fractures – what are the differences, and where are the gaps	7
Tropical pyomyositis	7
Novel therapies in axial spondyloarthritis	7
Insights into the genetic landscape of systemic sclerosis	7
Pain mechanisms for the practicing rheumatologist	7
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission	7
Novel therapies in SSc	7
Horizon scan: State-of-the-art therapeutics for psoriatic arthritis	6
Cardiovascular risk in vasculitis	6
Editorial Board	6
Myofascial pain – A major player in musculoskeletal pain	6
Advances in imaging techniques for Sjogren's disease	6
Pipeline treatments on psoriatic disease	6
Pre-RA: Can early diagnosis lead to prevention?	6
Interstitial lung disease imaging for autoimmune diseases	6
Utility of polygenic risk scores to aid in the diagnosis of rheumatic diseases	5
Vascular ultrasound in rheumatology practice	5
Management of pregnant with rheumatoid arthritis: Preconception care, pregnancy and lactation strategies, and maternal-fetal outcomes	5
Non-coding DNA variants for risk in lupus	5
To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question	5
Treatment overview of axial spondyloarthritis in 2023	5
New developments in ultrasound and MRI imaging of pediatric rheumatic diseases	5
Microbiota and immune dynamics in rheumatoid arthritis: Mechanisms and therapeutic potential	5
Cancer and myositis: Who, when, and how to screen	5
How to treat monogenic SLE?	4
Musculoskeletal manifestations in leprosy	4
Highlights of advancement in Rheumatoid Arthritis research and clinical practice	4
Cervicogenic headache – How to recognize and treat	4
Systemic lupus erythematosus and damage: What has changed over the past 20 years?	4
Practical approaches for clinicians in chronic pain management: Strategies and solutions	4
Magnetic resonance imaging in spondyloarthritis: Friend or Foe?	4
Osteoporosis and fragility fractures – Why is there still avoidable disability and death?	4
Deficiency of adenosine deaminase 2 (DADA2): Review	4
Structural disease modification in axial spondyloarthritis	4
Assessment of disease activity and damage in SLE: Are we there yet?	4
Challenges in the diagnosis of axial spondyloarthritis	4
Genetics of vasculitis	4
What is new in pharmacological treatment for osteoarthritis?	4
“Inflammatory or non-inflammatory pain in inflammatory arthritis – How to differentiate it?”	4
Clinical utility of ultrasound and MRI in rheumatoid arthritis: An expert review	4
Antiphospholipid syndrome in children	4
Editorial Board	4